NO can not reach these unventilated areas and instead vasodilates the vessels in the well-ventilated regions ... Therapeutic Role of Nitric Oxide in Respiratory Disease. MedGenMed 2(2), 2000 ...

The present study was undertaken to investigate the safety and efficacy of a mixture of nitric oxide (NO) and oxygen administered via a nasal cannula for 24 hours in patients with oxygen dependent ...

Beyond Air (XAIR) announced that the LungFit PH has received market authorization from the Australian Therapeutic Goods Administration for ...

BACKGROUND Airway hyperresponsiveness, induced sputum eosinophils, and exhaled nitric oxide (NO) levels have all been proposed as non-invasive markers for monitoring airway inflammation in patients ...

A randomised trial of patients who could not participate actively while ventilated but commence IMT within 1 ... PEEP >10 cmH 2 O, FiO 2 >0.60, nitric oxide, nebulised prostacyclin, high frequency ...

I found a simple in-office saliva test 9 that provides real-time information to reveal nitric oxide deficiencies. I tell patients: "It's an indicator; higher levels of NO are associated with blood ...

nitric oxide ventilation, organ transplantation, renal dialysis and high frequency oscillatory ventilation for patients. Post discharge, NICU graduates can be followed at Texas Children’s outpatient ...

We therefore sought to assess if systemic nitric oxide (NO) production is elevated in severe AP and determine whether this is a reflection of biochemical severity or endotoxin exposure. Patients and ...

OBJECTIVE To assess whether long term treatment with epoprostenol might restore primary non-responsiveness to nitric oxide (NO) in patients with primary pulmonary hypertension. METHODS Seven patients ...

* Beyond Air’s LungFit PH is approved for commercial use in the United States of America, European Union, Australia and New Zealand. Beyond Air’s other LungFit systems are not approved for commercial ...